These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Discovery of a New Inhibitor of Myeloid Differentiation 2 from Cinnamamide Derivatives with Anti-Inflammatory Activity in Sepsis and Acute Lung Injury. Chen G, Zhang Y, Liu X, Fang Q, Wang Z, Fu L, Liu Z, Wang Y, Zhao Y, Li X, Liang G. J Med Chem; 2016 Mar 24; 59(6):2436-51. PubMed ID: 26937738 [Abstract] [Full Text] [Related]
5. Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2. Zhang YL, Zhang WX, Yan JQ, Tang YL, Jia WJ, Xu ZW, Xu MJ, Chattipakorn N, Wang Y, Feng JP, Liu ZG, Liang G. Acta Pharmacol Sin; 2022 Jan 24; 43(1):76-85. PubMed ID: 34480112 [Abstract] [Full Text] [Related]
6. Targeting myeloid differentiation protein 2 by the new chalcone L2H21 protects LPS-induced acute lung injury. Zhang Y, Xu T, Wu B, Chen H, Pan Z, Huang Y, Mei L, Dai Y, Liu X, Shan X, Liang G. J Cell Mol Med; 2017 Apr 24; 21(4):746-757. PubMed ID: 27860279 [Abstract] [Full Text] [Related]
7. Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation. Zhang Y, Chen H, Zhang W, Cai Y, Shan P, Wu D, Zhang B, Liu H, Khan ZA, Liang G. Biochim Biophys Acta Mol Basis Dis; 2020 May 01; 1866(5):165683. PubMed ID: 31953218 [Abstract] [Full Text] [Related]
9. New MD2 inhibitors derived from curcumin with improved anti-inflammatory activity. Zhang Y, Liu Z, Wu J, Bai B, Chen H, Xiao Z, Chen L, Zhao Y, Lum H, Wang Y, Zhang H, Liang G. Eur J Med Chem; 2018 Mar 25; 148():291-305. PubMed ID: 29466778 [Abstract] [Full Text] [Related]
10. Discovery of new MD2 inhibitor from chalcone derivatives with anti-inflammatory effects in LPS-induced acute lung injury. Zhang Y, Wu J, Ying S, Chen G, Wu B, Xu T, Liu Z, Liu X, Huang L, Shan X, Dai Y, Liang G. Sci Rep; 2016 Apr 27; 6():25130. PubMed ID: 27118147 [Abstract] [Full Text] [Related]
11. Inhibition of myeloid differentiation factor 2 by baicalein protects against acute lung injury. Chen H, Zhang Y, Zhang W, Liu H, Sun C, Zhang B, Bai B, Wu D, Xiao Z, Lum H, Zhou J, Chen R, Liang G. Phytomedicine; 2019 Oct 27; 63():152997. PubMed ID: 31254764 [Abstract] [Full Text] [Related]
13. Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury by targeting MD2. Ye J, Guan M, Lu Y, Zhang D, Li C, Li Y, Zhou C. Eur J Pharmacol; 2019 Jun 05; 852():151-158. PubMed ID: 30807747 [Abstract] [Full Text] [Related]
14. Recent progress in the discovery of myeloid differentiation 2 (MD2) modulators for inflammatory diseases. Chen L, Fu W, Zheng L, Wang Y, Liang G. Drug Discov Today; 2018 Jun 05; 23(6):1187-1202. PubMed ID: 29330126 [Abstract] [Full Text] [Related]
15. L6H9 attenuates LPS-induced acute lung injury in rats through targeting MD2. Wu P, Yan H, Qi J, Jia W, Zhang W, Yao D, Ding C, Zhang Y, Chen M, Cai X. Drug Dev Res; 2020 Feb 05; 81(1):85-92. PubMed ID: 31693211 [Abstract] [Full Text] [Related]
16. Flavokawain B alleviates LPS-induced acute lung injury via targeting myeloid differentiation factor 2. Luo W, Yang LB, Qian CC, Ma B, Manjengwa GM, Miao XM, Wang J, Hu CH, Jin B, Zhang LX, Zheng C, Liang G, Wang Y. Acta Pharmacol Sin; 2022 Jul 05; 43(7):1758-1768. PubMed ID: 34737421 [Abstract] [Full Text] [Related]
19. Cardamonin inhibits LPS-induced inflammatory responses and prevents acute lung injury by targeting myeloid differentiation factor 2. Yang L, Luo W, Zhang Q, Hong S, Wang Y, Samorodov AV, Chattipakorn N, Pavlov VN, Liang G. Phytomedicine; 2021 Dec 05; 93():153785. PubMed ID: 34638032 [Abstract] [Full Text] [Related]